Legacy Trust’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$347K Buy
1,144
+3
+0.3% +$791 0.06% 175
2026
Q2
$252K Buy
1,141
+7
+0.6% +$1.94K 0.04% 187
2026
Q1
$335K Hold
1,134
– – 0.06% 165
2025
Q4
$310K Hold
1,134
– – 0.06% 165
2025
Q3
$306K Hold
1,134
– – 0.06% 158
2025
Q2
$313K Sell
1,134
-486
-30% -$132K 0.08% 119
2025
Q1
$430K Hold
1,620
– – 0.1% 115
2024
Q4
$376K Hold
1,620
– – 0.09% 120
2024
Q3
$357K Sell
1,620
-6
-0.4% -$1.24K 0.08% 126
2024
Q2
$320K Hold
1,626
– – 0.08% 124
2024
Q1
$350K Sell
1,626
-150
-8% -$31.5K 0.09% 129
2023
Q4
$374K Sell
1,776
-88
-5% -$18.8K 0.1% 120
2023
Q3
$373K Buy
1,864
+2
+0.1% +$398 0.11% 116
2023
Q2
$345K Sell
1,862
-54
-3% -$10K 0.1% 122
2023
Q1
$367K Sell
1,916
-60
-3% -$10.8K 0.11% 117
2022
Q4
$332K Buy
+1,976
New +$343K 0.1% 115

Other funds holding CME

Legacy Trust's CME Position: Q3 2026 in Review

Legacy Trust increased its CME Group (CME) stake by 0.26% in Q3 2026, buying an estimated $791 and bringing the position to 1,144 shares worth $347K. The position accounts for 0.06% of the portfolio, ranked #175.

Legacy Trust first reported a position in CME in Q4 2022 and has held it in 16 quarters since. The position peaked at $430K in Q1 2025. 1,007 funds tracked by Wall St. Rank hold CME as of Q3 2026.

  • Legacy Trust held 1,144 shares of CME Group worth $347K as of Q3 2026.
  • Legacy Trust bought 3 CME Group shares in Q3 2026, an estimated $791.
  • CME Group made up 0.06% of Legacy Trust's portfolio in Q3 2026, its #175 holding.
  • Legacy Trust first reported a position in CME Group in Q4 2022 and has held it in 16 quarters since.
  • Legacy Trust's CME Group position peaked at $430K in Q1 2025.
  • 1,007 funds tracked by Wall St. Rank held CME Group as of Q3 2026.

Based on Legacy Trust's 13F filing for Q3 2026, filed 6 Nov 2026.